Bisbenzamidines as antifungal agents. are both amidine functions required to observe an anti-Pneumocystis carinii activity?
- PMID: 20657441
- PMCID: PMC6257595
- DOI: 10.3390/molecules15064283
Bisbenzamidines as antifungal agents. are both amidine functions required to observe an anti-Pneumocystis carinii activity?
Abstract
A library of 19 novel 4-(4-phenylpiperazine-1-yl)benzamidines has been synthesized and evaluated in vitro against Pneumocystis carinii. Among these compounds, N-ethyl- and N-hexyl-4-(4-phenylpiperazine-1-yl)benzamidines emerged as the most promising compounds, with inhibition percentages at 10.0 microg/mL of 87% and 96%, respectively. Those compounds remained active at 0.1 microg/mL.
Figures
Similar articles
-
Highly active anti-Pneumocystis carinii compounds in a library of novel piperazine-linked bisbenzamidines and related compounds.Antimicrob Agents Chemother. 2004 Nov;48(11):4209-16. doi: 10.1128/AAC.48.11.4209-4216.2004. Antimicrob Agents Chemother. 2004. PMID: 15504843 Free PMC article.
-
Novel bisbenzamidines as potential drug candidates for the treatment of Pneumocystis carinii pneumonia.Bioorg Med Chem Lett. 2004 Sep 6;14(17):4545-8. doi: 10.1016/j.bmcl.2004.06.034. Bioorg Med Chem Lett. 2004. PMID: 15357989
-
In vitro selection and in vivo efficacy of piperazine- and alkanediamide-linked bisbenzamidines against Pneumocystis pneumonia in mice.Antimicrob Agents Chemother. 2006 Jul;50(7):2337-43. doi: 10.1128/AAC.00126-06. Antimicrob Agents Chemother. 2006. PMID: 16801410 Free PMC article.
-
Pafuramidine for Pneumocystis jiroveci pneumonia in HIV-infected individuals.Expert Rev Anti Infect Ther. 2007 Dec;5(6):921-8. doi: 10.1586/14787210.5.6.921. Expert Rev Anti Infect Ther. 2007. PMID: 18039076 Review.
-
Analysis of current antifungal agents and their targets within the Pneumocystis carinii genome.Curr Drug Targets. 2012 Nov;13(12):1575-85. doi: 10.2174/138945012803530107. Curr Drug Targets. 2012. PMID: 22934582 Free PMC article. Review.
Cited by
-
CanB, a Druggable Cellular Target in Mycobacterium tuberculosis.ACS Omega. 2023 Jul 3;8(28):25209-25220. doi: 10.1021/acsomega.3c02311. eCollection 2023 Jul 18. ACS Omega. 2023. PMID: 37483251 Free PMC article.
-
Diamidines versus Monoamidines as Anti-Pneumocystis Agents: An in Vivo Study.Pharmaceuticals (Basel). 2013 Jul 1;6(7):837-50. doi: 10.3390/ph6070837. Pharmaceuticals (Basel). 2013. PMID: 24276317 Free PMC article.
-
Synthesis and antifungal activity of benzamidine derivatives carrying 1,2,3-triazole moieties.Molecules. 2014 May 2;19(5):5674-91. doi: 10.3390/molecules19055674. Molecules. 2014. PMID: 24796390 Free PMC article.
References
-
- Donkor I.O., Queener S.F., Dalton J.T. Pentamidine congeners: DNA binding affinity and anti-Pneumocystis carinii activity of butamidine analogues. Bioorg. Med. Chem. Lett. 1996;6:1967–1970. doi: 10.1016/0960-894X(96)00353-8. - DOI
-
- Delia T.J., Nagarajan A., Queener S.F., Bartlett M.S. Ring-based analogues of pentamidine versus P. carinii pneumonia in culture. Bioorg. Med. Chem. Lett. 1996;6:2367–2370. doi: 10.1016/0960-894X(96)00427-1. - DOI
-
- Huang T.L., Vanden Eynde J.J., Mayence A., Collins M.S., Cushion M.T., Rattendi D., Londono I., Mazumder L., Bacchi C.J., Yarlett N. Synthesis and SAR of alcanediamide-linked bisbenzamidines with anti-trypanosomal and anti-pneumocystis activity. Bioorg. Med. Chem. Lett. 2009;19:5884–5886. doi: 10.1016/j.bmcl.2009.08.073. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources